Targeting the oncogenomic function of the E2F8 transcription factor in lethal prostate cancer

Ended Project Grant Awarded Last action

Award ID
W81XWH2210039
Recipient
Awarding agency
Obligated
$482,890

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Durham, NC 27708, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Department of the Army Medical Command awarded Duke University a $482,890 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from April 1, 2022 to March 31, 2024 to target the oncogenomic function of the E2F8 transcription factor in lethal prostate cancer. Through this funding, Duke University researchers will investigate medical solutions for prostate cancer at the genomic level, with the aim of transforming healthcare for service members and the public. The grant supports Duke University's basic, applied, and advanced biomedical research efforts focused on the molecular mechanisms driving aggressive prostate cancer progression.

Quick answers

Who received award W81XWH2210039?

W81XWH2210039 was awarded to Duke University by Medical Command (Department of the Army) on April 1, 2022.

How much is award W81XWH2210039 worth?

$482,890 has been obligated on W81XWH2210039.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login